JONATHAN HOLLOWAY: Open Payments
NPI 1760089841 · MOSCOW, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,695 in 68 payments from 18 companies in 2025. Trend: 2023 $524 · 2024 $1,005 · 2025 $1,695
Food & beverage: $1,500Education: $195
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $496 |
| Incyte Corporation | 9 | $181 |
| Novartis Pharmaceuticals Corporation | 14 | $148 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $143 |
| Lilly USA, LLC | 2 | $106 |
| SEAGEN INC. | 1 | $95 |
| PFIZER INC. | 5 | $88 |
| ABBVIE INC. | 4 | $81 |
| Eisai Inc. | 3 | $59 |
| Merck Sharp & Dohme LLC | 3 | $52 |
Products named: DATROWAY, VERZENIO, ENHERTU, IMFINZI, TAGRISSO, KISQALI, Lenvima, KEYTRUDA.
Industry payments across ID — which companies pay providers there.
